These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21403605)

  • 21. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay.
    Schneiderhan W; Diaz F; Fundel M; Zhou S; Siech M; Hasel C; Möller P; Gschwend JE; Seufferlein T; Gress T; Adler G; Bachem MG
    J Cell Sci; 2007 Feb; 120(Pt 3):512-9. PubMed ID: 17227797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
    Klomp HJ; Zernial O; Flachmann S; Wellstein A; Juhl H
    Clin Cancer Res; 2002 Mar; 8(3):823-7. PubMed ID: 11895915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
    Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.
    Erkan M; Michalski CW; Rieder S; Reiser-Erkan C; Abiatari I; Kolb A; Giese NA; Esposito I; Friess H; Kleeff J
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1155-61. PubMed ID: 18639493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
    Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
    Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression.
    Friess H; Yamanaka Y; Kobrin MS; Do DA; Büchler MW; Korc M
    Clin Cancer Res; 1995 Nov; 1(11):1413-20. PubMed ID: 9815939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
    Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
    J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer.
    Masugi Y; Yamazaki K; Hibi T; Aiura K; Kitagawa Y; Sakamoto M
    Hum Pathol; 2010 Aug; 41(8):1061-8. PubMed ID: 20413143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immune network in pancreatic cancer development and progression.
    Wörmann SM; Diakopoulos KN; Lesina M; Algül H
    Oncogene; 2014 Jun; 33(23):2956-67. PubMed ID: 23851493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer -- is there a correlation to tumour growth and liver metastasis?
    Heukamp I; Kilian M; Gregor JI; Kiewert C; Schimke I; Kristiansen G; Walz MK; Jacobi CA; Wenger FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 Apr; 74(4):223-33. PubMed ID: 16556492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
    Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
    Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance.
    Erkan M; Reiser-Erkan C; Michalski CW; Kong B; Esposito I; Friess H; Kleeff J
    Curr Mol Med; 2012 Mar; 12(3):288-303. PubMed ID: 22272725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic Stellate Cells: The Key Orchestrator of The Pancreatic Tumor Microenvironment.
    Thomas D; Radhakrishnan P
    Adv Exp Med Biol; 2020; 1234():57-70. PubMed ID: 32040855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic cancer stroma: controversies and current insights.
    Ansari D; Carvajo M; Bauden M; Andersson R
    Scand J Gastroenterol; 2017; 52(6-7):641-646. PubMed ID: 28276831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.